| Literature DB >> 23690783 |
Manisha Vaish1, Vineet K Singh.
Abstract
Nitric oxide and its derivative peroxynitrites are generated by host defense system to control bacterial infection. However certain Gram positive bacteria including Staphylococcus aureus possess a gene encoding nitric oxide synthase (SaNOS) in their chromosome. In this study it was determined that under normal growth conditions, expression of SaNOS was highest during early exponential phase of the bacterial growth. In oxidative stress studies, deletion of SaNOS led to increased susceptibility of the mutant cells compared to wild-type S. aureus. While inhibition of SaNOS activity by the addition of L-NAME increased sensitivity of the wild-type S. aureus to oxidative stress, the addition of a nitric oxide donor, sodium nitroprusside, restored oxidative stress tolerance of the SaNOS mutant. The SaNOS mutant also showed reduced survival after phagocytosis by PMN cells with respect to wild-type S. aureus.Entities:
Year: 2013 PMID: 23690783 PMCID: PMC3638668 DOI: 10.1155/2013/312146
Source DB: PubMed Journal: Int J Microbiol
Figure 1PCR verification of a mutation in the SaNOS gene in S. aureus. Primers P7 (5′-ATACAGAAGAAGAACTTATTTATGG-3′) and P8 (5′- CACCTCTACTAACTTAATGATGG-3′) were used in the PCR that allowed amplification of a 963 bp product (lane 1) when genomic DNA from wild-type S. aureus strain SH1000 was used. These primers amplified a ~2.4 kb fragment when genomic DNA from the SaNOS mutant of S. aureus strains SH1000 was used as template (lanes 2). Lane 3: PCR product when genomic DNA from the SaNOS mutants of S. aureus strains SH1000 complemented in trans with SaNOS was used as template. The larger PCR product is not seen because of complementation with wild-type SaNOS gene on a high copy plasmid pCU1. Lane M: DNA ladder.
Expression of SaNOS in S. aureus during different phases of growth.
| Growth stage |
|
|---|---|
| Early-exponential | 100% |
| Mid-exponential | 19.48% |
| Late-exponential | 10.73% |
| Stationary | 4.90% |
*Expression of SaNOS is shown relative to its transcript level during early-exponential phase of growth.
Nitric oxide synthase activity in different S. aureus strains.
| Strain | NOS activity (%)* |
|---|---|
| SH1000 | 3.95 ± 1.61 |
| SH1000Δ | 0 |
| Complemented strain | 26.47 ± 3.95 |
*%Citrulline formed in relation to total L-arginine used in the assay. Citrulline conversion in the mutant strain was below the background level (control reaction with no protein extract). Values represent average of three independent experiments ± standard deviation.
Figure 2(a) Survival of S. aureus SH1000, its isogenic SaNOS mutant, and the mutant complemented with SaNOS gene in trans from a lethal dose (350 mM) of H2O2 with and without supplementation with 1 mM L-arginine. (b) Survival of wild-type S. aureus SH1000 pretreated with 5 mM L-NAME from 350 mM H2O2. (c) Survival of SaNOS mutant of S. aureus SH1000 pre-treated with 2.5 mM sodium nitroprusside from 350 mM H2O2. *Significant at P < 0.05.
Figure 3S. aureus survival in neutrophil cells. Neutrophil cells were infected (MOI 1 : 2.5) with wild-type S. aureus SH1000 and its isogenic SaNOS mutant for 1 h at 37°C and then plated on TSA plate. *Significant at P < 0.05.